- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07547683
Usability of the Regen Gait Therapy Robot in Healthy Adults
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Physical therapy, despite its effectiveness, is a physically demanding profession that requires moderate to high physical and psychological work demands. A single session typically lasts close to an hour per patient, with a substantial portion dedicated to hands-on rehabilitation therapy, excluding assessment. Long sessions, repetitive manual motions, and awkward postures contribute to fatigue, risk of musculoskeletal strain, and limited treatment duration.
One of such physically demanding tasks in rehabilitation is gait training, which often requires therapists to provide continuous manual assistance to a patient's lower limbs during treadmill walking or overground training. This repetitive, non-ergonomic work not only accelerates therapist fatigue and low back pain but also restricts the number of gait cycles that can be practiced, thereby limiting patient outcomes. These challenges create a growing need for robotic technology that can share the physical workload while maintaining therapy quality.
Rehabilitation robotic technology ranges from exoskeletons to end-effector-based assisted training devices. These provide precision, repeatability, and adaptability beyond traditional therapy methods, while also providing sensory and motor feedback. Despite these advantages, current robotic devices still face significant barriers to widespread adoption. Most rehabilitation robots either provide fixed-repetitive motions, work on just one joint, or require extensive pre-programming, which limits adaptability and versatility to individual patient needs. Further, high equipment costs, the need for specialized staff training, and required adaptations to clinical infrastructure often limit their accessibility and scalability.
Regen offers a potential solution to these gaps. Regen is a medical robotic technology aimed at improving the strength and mobility of patients. This device consists of a human-interactive robot arm that connects patients via an arm or leg brace, providing therapeutic motions to patients. It works by replicating therapist-guided movements, extending therapy duration, and ensuring consistent motion delivery. Regen is unique in its "assist-as-needed" capability. This allows the therapist to directly teach and calibrate new trajectories for each user, set repetitions, and then run based on the patient's abilities. This adaptability not only supports patient progression but also enhances motivation for the patient. Thus, the system is more responsive to the real-world variability of therapy sessions.
Before such systems can be brought into clinical practice, it is essential to evaluate usability and validity. Usability assesses whether the system is acceptable, safe, and easy to use for both therapists and patients. Validity assesses the system's ability to accurately replicate therapeutic movement trajectories.
The primary aim of this study is to evaluate the feasibility and usability of Regen in young healthy adults. The secondary aim is to assess the validity of the device in replicating therapist-guided movement using a marker-based motion capture system. The investigators hypothesize that Regen is a safe, usable, and valid tool for delivering therapist-like rehabilitation movements.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Mac Prible, PhD
- Phone Number: 6466208829
- Email: prible@utexas.edu
Study Contact Backup
- Name: Sonu Maharjan, MS
- Phone Number: 6823743674
- Email: sm86245@my.utexas.edu
Study Locations
-
-
Texas
-
Austin, Texas, United States, 78712
- Recruiting
- University of Texas at Austin
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Healthy study participants: adults (18-50 years) who can walk independently on a treadmill for at least 6 minutes
- Physical therapist (PT) with a license and experience in gait rehab (self-reported)
Exclusion Criteria:
(1) For healthy study participants:
- Any neurological or orthopedic condition that can affect walking (Self-reported)
- Uncontrolled cardiovascular or metabolic condition that can affect walking (Self-reported)
- Current lower-limb pain or discomfort
- Lower-limb surgery within the past six months
- On medications that may impair balance (Self-reported)
- Open wound in the lower limb
(2) For PT:
- Not having license
- No experience in gait rehab
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Regen-assisted gait feasibility and usability arm
Single experimental arm in which all participants complete treadmill walking under therapist-assisted and Regen-assisted conditions, to evaluate the feasibility and usability of the Regen robotic gait therapy system.
|
Regen is a robotic gait therapy device that learns therapist-guided movement trajectories and autonomously reproduces them.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
System Usability Scale (SUS)
Time Frame: During the experimental session (Day 1) and immediately post-task (within 10 minutes after completion)
|
The System Usability Scale (SUS) will be used to assess the usability of the device.
The SUS consists of 10 items scored on a 5-point Likert scale and converted to a total score ranging from 0 to 100, with higher scores indicating better usability.
|
During the experimental session (Day 1) and immediately post-task (within 10 minutes after completion)
|
|
NASA Task Load Index (NASA-TLX)
Time Frame: During the experimental session (Day 1) and immediately post-task (within 10 minutes after completion)
|
The NASA Task Load Index (NASA-TLX) will be used to assess perceived workload across six domains (mental demand, physical demand, temporal demand, performance, effort, and frustration).
Scores range from 0 to 100, with higher scores indicating greater workload.
|
During the experimental session (Day 1) and immediately post-task (within 10 minutes after completion)
|
|
Device Acceptability (Likert Scale)
Time Frame: Immediately post-task (within 10 minutes after completion, Day 1)
|
Participants will rate safety, comfort, ease of use, and satisfaction using 5-point Likert scale items.
Higher scores indicate greater acceptability of the device.
|
Immediately post-task (within 10 minutes after completion, Day 1)
|
|
Qualitative Feedback on Device Usability and Safety
Time Frame: Immediately post-task (within 10 minutes after completion, Day 1)
|
Open-ended questions will be used to collect qualitative feedback from participants and therapists regarding device usability, safety, and overall experience.
|
Immediately post-task (within 10 minutes after completion, Day 1)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Hao-Yuan Hsiao, PhD, University of Austin at Texas
Publications and helpful links
General Publications
- Zbytniewska M, Kanzler CM, Jordan L, Salzmann C, Liepert J, Lambercy O, Gassert R. Reliable and valid robot-assisted assessments of hand proprioceptive, motor and sensorimotor impairments after stroke. J Neuroeng Rehabil. 2021 Jul 16;18(1):115. doi: 10.1186/s12984-021-00904-5.
- Giansanti D. The Social Robot in Rehabilitation and Assistance: What Is the Future? Healthcare (Basel). 2021 Feb 25;9(3):244. doi: 10.3390/healthcare9030244.
- Banyai AD, Brisan C. Robotics in Physical Rehabilitation: Systematic Review. Healthcare (Basel). 2024 Aug 29;12(17):1720. doi: 10.3390/healthcare12171720.
- Jing Q, Xing Y, Duan M, Guo P, Cai W, Gao Q, Gao R, Ji L, Lu J. Study on the Rehabilitation Therapist Estimation Under Institutional Perspective by Applying the Workload Indicators of Staffing Needs in the Aging Context. Front Public Health. 2022 Jun 16;10:929675. doi: 10.3389/fpubh.2022.929675. eCollection 2022.
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- STUDY00008251
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Adult Participants
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Not yet recruitingHealthy Participants | Healthy Adult ParticipantsUnited States
-
University of PalermoCompletedHealthy Participants | Healthy Adult Participants | Healthy Young AdultsItaly
-
Universidad San SebastiánAgencia Nacional de Investigación y DesarrolloNot yet recruitingHealthy | Healthy Adult ParticipantsChile
-
Dragonfly TherapeuticsRecruitingHealthy | Healthy Participants | Healthy Adult Females | Volunteer | Healthy Adult MaleAustralia
-
Umm Al-Qura UniversityActive, not recruitingHealthy | Healthy Participants | Healthy Adult | Healthy Women | Healthy Adult Females | Healthy Adult Participants | Healthy Young Adults | Healthy Adult Female Participants | Healthy Adult Male | Poor Sleep Quality | Healthy (Controls) | Poor Sleeping Quality | Healthy Adult Male Subjects | Health Adult SubjectsSaudi Arabia
-
University of MinnesotaNot yet recruitingHealthy Adult ParticipantsUnited States
-
Baylor UniversityTempleton World Charity FoundationNot yet recruitingHealthy Adult ParticipantsUnited States
-
Yale UniversityNational Institute of Mental Health (NIMH)RecruitingHealthy Adult ParticipantsUnited States
-
University of California, DavisRecruiting
-
Northern Illinois UniversityMayo ClinicNot yet recruitingAcute Effects of Alpha-glycerylphosphorylcholine (A-GPC) on Lower Body Muscular Performance. (A-GPC)Healthy Adult ParticipantsUnited States
Clinical Trials on Regen Rehabilitation Assistive Device
-
Portland VA Medical CenterOregon Health and Science UniversityCompleted
-
Ain Shams UniversityNot yet recruiting
-
Politecnico di MilanoIRCCS Eugenio Medea; Villa Beretta Rehabilitation CenterCompletedMuscular Dystrophies | Muscular Dystrophy, Duchenne | Muscular Dystrophy, Becker | Muscular Dystrophy, Limb-Girdle Type 2Italy
-
Rocket Pharmaceuticals Inc.Completed
-
Hiroshima UniversityNot yet recruitingStroke | Disability Physical
-
NYU Langone HealthWithdrawnHearing LossUnited States
-
Taipei Medical University Shuang Ho HospitalSponsor GmbHCompleted
-
The Hong Kong Polytechnic UniversityLogistics and Supply Chain MultiTech R&D Centre, Hong KongRecruitingHealthy Male and Female SubjectsHong Kong
-
University of California, Los AngelesUniversity of Southern CaliforniaRecruiting
-
University of Colorado, DenverNot yet recruitingFecal Incontinence | Spina Bifida